Inflammatory mediators implicated in MS pathogenesis, including interleukins and tumor necrosis factor-alpha, have been identified in the renal tissues of individuals with renal abnormalities.[6] This systemic immune dysregulation may contribute to the development or exacerbation of renal dysfunction in MS patients. This evidence concerns the gene TNF and myeloid sarcoma.